TRFE.D Stock Overview
Operates as a compounding pharmacy that offers customized medications, generic drugs, and rapid prescription processing. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Polomar Health Services, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.26 |
| 52 Week High | US$1.50 |
| 52 Week Low | US$0.26 |
| Beta | 0 |
| 11 Month Change | -78.71% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -81.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| TRFE.D | US Consumer Retailing | US Market | |
|---|---|---|---|
| 7D | 0% | 4.9% | 1.6% |
| 1Y | n/a | 53.0% | 32.3% |
Return vs Industry: Insufficient data to determine how TRFE.D performed against the US Consumer Retailing industry.
Return vs Market: Insufficient data to determine how TRFE.D performed against the US Market.
Price Volatility
| TRFE.D volatility | |
|---|---|
| TRFE.D Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 6.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: TRFE.D's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine TRFE.D's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2023 | n/a | n/a | www.polomarsp.com |
Polomar Health Services, Inc. operates as a compounding pharmacy that offers customized medications, generic drugs, and rapid prescription processing. The company offers Tofacitinib that treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and Sildenafil (Generic Viagra) that improves blood to treat erectile dysfunction and pulmonary hypertension. It also offers skincare products.
Polomar Health Services, Inc. Fundamentals Summary
| TRFE.D fundamental statistics | |
|---|---|
| Market cap | US$7.07m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs TRFE.D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRFE.D income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did TRFE.D perform over the long term?
See historical performance and comparison